Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Acasti Pharma Inc. (ACST)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
3 days ago | GlobeNewsWire
2 weeks ago | GlobeNewsWire
3 weeks ago | GlobeNewsWire
a month ago | Pulse2
a month ago | PRNewsWire
a month ago | Pulse2
a month ago | Proactive Investors
3 months ago | GlobeNewsWire
3 months ago | Business Wire
3 months ago | Pulse2
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.